Cardiac stress test or cardiac diagnostic test involves measuring heart’s ability to respond to external stress in a controlled clinical environment, which is either induced by exercise or by drug stimulation. Cardiopulmonary stress testing is performed to evaluate exercise capacity and predict outcome in patients diagnosed with heart failure. The cardiac stress test is done with heart stimulation, either by exercise on a treadmill, with the patient connected to an electrocardiogram (ECG). Cardiopulmonary stress testing (CPST) plays an important role in the detection of ischemic heart disease, heart failure, shortness of breath, asthma, and other pulmonary disorders. CPST is a non-invasive and highly sensitive stress test that assesses the response of pulmonary, cardiovascular, neurophysiological, hematopoietic, and skeletal muscle systems to exercise.
The global cardiopulmonary stress testing devices market report provides market size estimates (Revenue US$ million – 2014 to 2021) for key market segments based on the type of cardiac stress testing monitors used (CPET/CPEx, desktop and portable CPET, pulse oximeter, SPECT/SPET, ECG, and stress blood pressure monitors) and forecasts growth trends (CAGR% – 2017 to 2021).
The global cardiopulmonary stress testing devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global cardiopulmonary stress testing devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global cardiopulmonary stress testing devices market and included in this report are CareFusion Corporation, COSMED, GE Healthcare, MGC Diagnostics Corporation, Nihon Kohden Corporation, Philips Healthcare, Schiller AG, Spacelabs Healthcare, SunTech Medical, Inc., and Welch Allyn, Inc.